Latest News
PRESS RELEASE
OCTOBER 25, 2023
Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody
PORTFOLIO NEWS
DECEMBER 20, 2023
Savara Added to the NASDAQ Biotechnology Index
PORTFOLIO NEWS
DECEMBER 15, 2023
Savara Announces New Employment Inducement Grant
PORTFOLIO NEWS
DECEMBER 06, 2023
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
PORTFOLIO NEWS
DECEMBER 06, 2023